The author responds to criticisms of the British National Formulary (BNF) by Drs. Srinivasan and Birch, clarifying that the BNF's dosages are based on data sheet doses approved by the UK Licensing Authority. The BNF serves as a practical guide for general practice, produced under the authority of a Joint Formulary Committee with input from various medical organizations. The committee has resisted including higher doses of antipsychotics than those licensed but acknowledges the need for adjustments in some cases. The Royal College Consensus Group has welcomed the BNF's cooperation. Additionally, the BNF aligns with clinical guidelines for lithium use. Susan Carvill, a nurse at Central Hospital, Warwick, audits neuroleptic usage in acute patients and finds that over 68% of patients are on neuroleptics, with many receiving additional p.r.n. prescriptions, potentially exceeding BNF dose guidelines. She suggests a time limit on p.r.n. medication to prevent side effects. Brian O'Shea's study on the helpfulness of the medical profession in voluntary schizophrenia organizations received no response from the National Schizophrenia Fellowship in the UK. The author, who interviewed relatives of the NSF/UK, notes this surprising lack of engagement.The author responds to criticisms of the British National Formulary (BNF) by Drs. Srinivasan and Birch, clarifying that the BNF's dosages are based on data sheet doses approved by the UK Licensing Authority. The BNF serves as a practical guide for general practice, produced under the authority of a Joint Formulary Committee with input from various medical organizations. The committee has resisted including higher doses of antipsychotics than those licensed but acknowledges the need for adjustments in some cases. The Royal College Consensus Group has welcomed the BNF's cooperation. Additionally, the BNF aligns with clinical guidelines for lithium use. Susan Carvill, a nurse at Central Hospital, Warwick, audits neuroleptic usage in acute patients and finds that over 68% of patients are on neuroleptics, with many receiving additional p.r.n. prescriptions, potentially exceeding BNF dose guidelines. She suggests a time limit on p.r.n. medication to prevent side effects. Brian O'Shea's study on the helpfulness of the medical profession in voluntary schizophrenia organizations received no response from the National Schizophrenia Fellowship in the UK. The author, who interviewed relatives of the NSF/UK, notes this surprising lack of engagement.